Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Ranogelan 375 mg prolonged-release tablets

Active Ingredient:
ranolazine
Company:  
G.L Pharma UK Limited See contact details
ATC code: 
C01EB18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 01 Jul 2024
{pdf} View or print the patient leaflet as PDF
G.L Pharma UK Limited
Company image
Address
Suite 3A, 30 St Thomas Place, Cambridgeshire Business Park, Ely, Cambridgeshire, CB7 4EX, UK
WWW
https://gl-pharma.com/enuk/
Medical Information Direct Line
01353 882875
Medical Information e-mail
[email protected]
Customer Care direct line
01353 882870